GR-89696
Appearance
IUPAC ime | |
---|---|
methyl 4-[2-(3,4-dichlorophenyl)acetyl]-3-(pyrrolidin-1-ylmethyl)piperazine-1-carboxylate | |
Identifikatori | |
CAS broj | 126766-32-3 |
PubChem | CID 3505 |
Hemijski podaci | |
Formula | C19H25Cl2N3O3 |
Molarna masa | 414.325 g/mol |
|
GR-89696 je lek koji deluje kao visoko selektivni κ-opioidni agonist.[1] On pokazuje selektivno dejstvo u različitim životinjskim modelima, i smatra se da je on selektivan za κ2 tip receptora.[2][3][4] Nedavne studije indiciraju da su GR-89696 i srodni κ2-selektivni agonisti korisni u sprečavanju svrabeža koji je uobičajena nuspojava konvencionalnih opioidnih analgetika, bez dodatnih nuspojava ne-selektivnih kapa agonista.[5]
Reference
[uredi | uredi izvor]- ^ Naylor A, Judd DB, Lloyd JE, Scopes DI, Hayes AG, Birch PJ (1993). „A potent new class of kappa-receptor agonist: 4-substituted 1-(arylacetyl)-2-[(dialkylamino)methyl]piperazines”. Journal of Medicinal Chemistry. 36 (15): 2075—83. PMID 8393489.
- ^ Herrero JF, Headley PM (1993). „Functional evidence for multiple receptor activation by kappa-ligands in the inhibition of spinal nociceptive reflexes in the rat”. British Journal of Pharmacology. 110 (1): 303—9. PMC 2176008 . PMID 8220893.
- ^ Ho J, Mannes AJ, Dubner R, Caudle RM (1997). „Putative kappa-2 opioid agonists are antihyperalgesic in a rat model of inflammation”. The Journal of Pharmacology and Experimental Therapeutics. 281 (1): 136—41. PMID 9103490.
- ^ Butelman ER, Ko MC, Traynor JR, Vivian JA, Kreek MJ, Woods JH (2001). „GR89,696: a potent kappa-opioid agonist with subtype selectivity in rhesus monkeys”. The Journal of Pharmacology and Experimental Therapeutics. 298 (3): 1049—59. PMID 11504802.
- ^ Ko MC, Husbands SM (2009). „Effects of atypical kappa-opioid receptor agonists on intrathecal morphine-induced itch and analgesia in primates”. The Journal of Pharmacology and Experimental Therapeutics. 328 (1): 193—200. PMC 2719014 . PMID 18842704. doi:10.1124/jpet.108.143925.
Spoljašnje veze
[uredi | uredi izvor]
Molimo Vas, obratite pažnju na važno upozorenje u vezi sa temama iz oblasti medicine (zdravlja). |